KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Accumulated Expenses (2016 - 2025)

Bausch Health Companies' Accumulated Expenses history spans 17 years, with the latest figure at $3.3 billion for Q4 2025.

  • For Q4 2025, Accumulated Expenses fell 4.16% year-over-year to $3.3 billion; the TTM value through Dec 2025 reached $3.3 billion, down 4.16%, while the annual FY2025 figure was $3.3 billion, 4.16% down from the prior year.
  • Accumulated Expenses for Q4 2025 was $3.3 billion at Bausch Health Companies, down from $3.6 billion in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $5.1 billion in Q2 2021 and bottomed at $2.9 billion in Q1 2023.
  • The 5-year median for Accumulated Expenses is $3.4 billion (2024), against an average of $3.7 billion.
  • The largest annual shift saw Accumulated Expenses grew 18.85% in 2021 before it tumbled 41.11% in 2022.
  • A 5-year view of Accumulated Expenses shows it stood at $4.8 billion in 2021, then tumbled by 37.63% to $3.0 billion in 2022, then grew by 4.85% to $3.1 billion in 2023, then rose by 11.36% to $3.5 billion in 2024, then dropped by 4.16% to $3.3 billion in 2025.
  • Per Business Quant, the three most recent readings for BHC's Accumulated Expenses are $3.3 billion (Q4 2025), $3.6 billion (Q3 2025), and $3.5 billion (Q2 2025).